Exogenous surfactant suppresses inflammation in experimental endotoxin-induced lung injury

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 28, Issue 4, 2009, Pages 341-349

  Mittal, Neha ^a   Sanyal, Sankar Nath ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

ARDS; COX 1; COX 2; Lipopolysaccharide; Reactive oxygen species; SP A; Surfactant; TUNEL

Indexed keywords

ACETOACETIC ACID; APOLIPOPROTEIN A; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICHLOROFLUORESCEIN; DIPALMITOYLPHOSPHATIDYLCHOLINE; ENDOTOXIN; EOSIN; HEMATOXYLIN; HEXADECANOL; LIPOPOLYSACCHARIDE; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; SURFACTANT; TYLAXOPOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG INJURY; MACROPHAGE; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

RATTUS; SUS;

EID: 77149130526     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v28.i4.80     Document Type: Article

References (35)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2:319-323
2. Suwabe A, Otake K, Yakuwa N, Suzuki H, Ito M, Tomoika H, Saito Y, Takahashi K. Artificial surfactant (surfactant TA) modulates adherence and superoxide production of neutrophils. Am J Respir Crit Care Med. 1998;158:1890-1899
3. Suwabe A, Takahashi S, Yasui SA, Sendo F. Bleomycin-stimulated hamster alveolar macrophages release interleukin-1. Am J Pathol. 1988; 132:512-520
4. Osanai K, Takahashi K, Sato S. Changes of lung surfactant and pressure-volume curve in bleomycin-induced pulmonary fibrosis. J Appl Physiol. 1991;70:1300-1308
5. Possmayer F. A proposed nomenclature for pulmonary surfactant-associated proteins. Am Rev Respir Dis. 1988;138:990-998
6. Persson A, Chang D, Crouch E. Surfactant protein D is a divalent cation-dependent carbohydrate- binding protein. J Biol Chem. 1990;265: 5755-5760
7. Van Iwaarden F, Welmers B, Verhoef J, Haagsman HP, Van Golde LM. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol. 1990;2:91-98
8. Kremlev SG, Phelps DS. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am J Physiol. 1994;267:L712-9.
9. Wright JR, Youmans DC. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macro phages. Am J Physiol. 1993;264:L338-44.
10. Enhorning G. Surfactant replacement in adult respiratory distress syndrome. Am Rev Respir Dis. 1989;140:281-283
11. Hasleton PS, Roberts TE. Adult respiratory distress syndrome-an update. Histopatholgy. 1999;34:285-294
12. Fink MP. Prostaglandins and sepsis: still a fascinating topic despite almost 40 years of research. Am J Physiol Lung Cell Mol Physiol. 2001;281:L534-6.
13. Lukkarinen H, Laine J, Aho H, Asikainen E, Penttinen P, Kaapa P. Inhibition of COX-2 aggravates neutrophil migration and pneumocyte apoptosis in surfactant-depleted rat lungs. Pediatr Res. 2006;59:412-417
14. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby DA. Inducible isofoms of cyclooxygenase and nitric oxide synthase in inflammation. Proc Natl Acad Sci U S A. 1994;91:2046-2050
15. Suzuki Y, Nakai E-ichi, Ohkawa K-ichi. Experimental studies on the pulmonary surfactant. Reconstitution of surface active material. J Lipid Res. 1982;23:53-61.
16. Raczka E, Kukowska-Latallo JF, Rymaszewski M, Chen C, Baker JR Jr. The effect of synthetic surfactant exosurf on gene transfer in mouse lung in vivo. Gene Ther. 1998;5:1333-1339
17. Malloy JL, Wright JR. In vivo clearance of surfactant lipids during acute pulmonary inflammation. Resp Res. 2004;5:1-9.
18. Pearse AGE. Histochemistry, theoretical and applied. 3rd ed. Vol.1. London: Churchill Livingstone; 1968. p. 660.
19. Holt PG, Degebrodt A, Venaille T, O'Leary C, Krska K, Flexman J, Farrell H, Shellam G, Young P, Penhale J, Papadimitriou JM. Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays. Immunol. 1985;54:139-147
20. Kerecman J, Mustafa SB, Vasquez MM, Dixon PS, Catro R. Immunosuppressive properties of surfactant in alveolar macrophage NR8383. Inflamm Res. 2008;57:118-125
21. Ermert L, Ermert M, Merkle M, Goppelt-Struebe M, Duncker HR, Grimminger F, Seeger W. Rat pulmonary cyclooxygenase-2 expression in response to endotoxin challenge: differential regulation in the various types of cells in the lung. Am J Pathol. 2000;156:1275-1287
22. Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol. 2005;174:5033-5039
23. Cuzzocrea S, Mazzon E, Sautebin L, Dugo L, Serrains I, De Sarro A, Caputi AP. Protective effects of celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat. Biochem Pharmacol. 2002;63:785-795
24. Saito T, Rodger IW, Hu F, Robinson R, Huynh T, Giaid A. Inhibition of COX pathway in experimental myocardial infarction. J Mol Cell Cardiol. 2004;37:71-77
25. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and non ulcerogenic. Proc Natl Acad Sci U S A. 1994;91:3228-3232
26. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999;5:698-701.
27. Hempel SL, Monick MM, Hunninghake GW. Lipopolysaccharide a prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest. 1994; 93:391-396
28. Ermert L, Ermert M, Goppelt-Struebe M, Walmrath D, Grimminger F, Steudel W, Ghofrani HA, Homberger C, Duncker HR, Seeger W. Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am J Respir Cell Mol Biol. 1998;18:479-488
29. McIntosh JC, Swyers AH, Fisher JH, Wright JR. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol. 1996;15:509-519
30. Sugahara K, Iyama K, Sano K, Kuroki Y, Akino T, Matsumoto M. Overexpression of surfactant protein SP-A, SP-B and SP-C mRNA in rat lungs with lipopolysaccharide-induced injury. Lab Invest. 1996;74:209-220
31. Schochett P, Mora R, Mark L, Butler M, Ingenito EP. Calcium dependent degradation of surfactant protein A by activated neutrophils due to serine proteases. Exp Lung Res. 1999;25:595-616.
32. Ryan SF, Ghassibi Y, Liau DF. Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro. Am J Respir Cell Mol Biol. 1991;4:33-41.
33. Mark L, Ingenito EP. Surfactant function and composition after free radical exposure generated by transition metals. Am J Physiol (Lung Cell Mol Physiol). 1999;276:L491-500.
34. Ingenito EP, Mora R, Sonna LA, Cullivan M, Marzan Y, Halley K, Mark L. Decreased surfactant protein B expression and surfactant dysfunction in a murine model of acute lung injury. Am J Respir Cell Mol Biol. 2001;25:35-44.
35. Gregory T, Longmore WJ, Moxley MA, Whitsett JA. Surfactant chemical composition and the biophysical activity in the acute respiratory distress syndrome. J Clin Invest. 1991;88:1976-1981